ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
68,094.11
0.55%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Black Diamond Therapeutics Inc (BDTX)

  7. Black Diamond Therapeutics Inc (BDTX) News

Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDTX
DateTimeSourceHeadlineSymbolCompany
01/06/202415:00GlobeNewswire Inc.Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
29/05/202413:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Jefferies Global Healthcare ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/05/202400:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202412:30GlobeNewswire Inc.Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202412:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
24/04/202421:05GlobeNewswire Inc.Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/04/202413:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Changes to Board of DirectorsNASDAQ:BDTXBlack Diamond Therapeutics Inc
07/04/202423:00GlobeNewswire Inc.Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
03/04/202413:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/03/202412:00GlobeNewswire Inc.Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/03/202417:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
05/03/202421:30GlobeNewswire Inc.Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
28/02/202413:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202422:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202422:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202422:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/02/202415:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BDTXBlack Diamond Therapeutics Inc
18/01/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/01/202413:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/01/202413:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Corporate Update and Expected 2024 MilestonesNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202312:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202312:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMNASDAQ:BDTXBlack Diamond Therapeutics Inc
07/11/202313:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202312:45GlobeNewswire Inc.Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202312:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202312:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/10/202317:30GlobeNewswire Inc.Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535NASDAQ:BDTXBlack Diamond Therapeutics Inc
04/10/202317:14GlobeNewswire Inc.Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:BDTXBlack Diamond Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BDTX

Your Recent History

NYSE
VKQ
Invesco Municipal
LSE
CLK
Cityblock
NYSE
DESK
VanEck ETF Trust
NASDAQ
BNSO
Bonso Electronics
BIT
S32120
Societe Generale Effekten
TSXV
DOGS
Fridays Dog
LSE
MFAI
Mindflair
USOTC
YTRGF
YT Realty (PK)
AMEX
TZA
Direxion Daily Small Cap...
USOTC
BTEGF
Baytex Energy (PK)
USOTC
AGRUF
AF Gruppen ASA (PK)
TSX
MFC.PR.J
Manulife Financial
TSX
BAM.PR.E
Brookfield Asset Managem...
LVCN
HVNBTC
Hiveterminal Token
LSE
XPG
Xpertise
AMEX
RMB
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved